α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
about
A Molecular Basis for NKT Cell Recognition of CD1d-Self-AntigenSerological and immunochemical characterization of anti-PP1Pk (anti-Tja) antibodies in blood group little p individuals. Blood group A type 4 recognition due to internal bindingMonoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomainsSynthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1----3N-acetylglucosaminyltransferase.The 3G11+ antigen, a marker for murine CD4+ TH1 lymphocytes, is a ganglioside.Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.Characterization of porcine kidney neutral glycosphingolipids: identification of a carbohydrate antigen recognized by human natural antibodies.On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry.A recombinant hybrid peptide composed of AAF adhesin of enteroaggregative Escherichia coli and Shiga toxin B subunit elicits protective immune response in mice.Production of monoclonal antibodies specific for ganglioside GD3.Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.A verotoxin 1 B subunit-lambda CRO chimeric protein specifically binds both DNA and globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb(3) positive cells.Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.Linear synthesis of the tumor-associated carbohydrate antigens Globo-H, SSEA-3, and Gb3.Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease.Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry.Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease.Shiga toxin B-subunit sequential binding to its natural receptor in lipid membranes.Cellular and tissue localization of globotriaosylceramide in Fabry disease.Substrate specificity of ceramide trihexosidase.Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease
P921
Q27667172-77A1E958-F3BE-4892-8798-FE0CAAE327B4Q28318833-89740E92-9A1D-4AE3-9232-9795CC9BC571Q28339128-7835D1E7-CB1E-4BDA-9CE0-585582BF5FC8Q33381259-56603822-BD43-49C8-A3FB-B657A74E43B5Q33389321-1CC07B6B-53B1-4B88-89D3-4549C555CFB8Q33798933-1FCA1485-0D48-4F52-A3CC-1567191C9C0EQ34563125-35637E1E-5146-4E52-B35B-0DD44607DC45Q38317394-B2135E9B-376A-4AED-9740-FF6C533CCEF6Q40028252-B74EF90B-6124-4777-9132-B6FC34647D16Q42280573-9B9D9CAE-CFBC-45A3-85CC-09D408870010Q42972836-F7D03EFF-1431-49B5-B772-C96E28500F0DQ43298547-AB193679-7A7F-4CE5-A6A8-5CF6770719D1Q43604576-E3DC3ADD-BA9D-4C7A-BD4D-50D8AA096958Q43661975-C237E966-F144-4A96-A975-3971DACB48E4Q43721908-5CE2178A-643E-4477-AE05-C37E7A2C377CQ43850028-9ACA6BC1-391F-45C3-ADCA-ED731592707EQ44134817-8B83AA67-523E-49C0-BDE1-478142485D5EQ44151257-BBD5DA3A-6D22-423B-8B3D-2A781291A13BQ44868882-6C6D84DA-4229-4040-921F-A435D316A558Q46667292-F849F561-B7E9-4665-8565-7488EA6D677FQ50472301-9C02D5E5-1E3C-46A1-8690-B5D7D951B4E6Q51979382-4E019B43-2DB4-4F84-B47D-67CC71CE1497Q55035780-0964CF79-0CB8-4F81-A87C-2C4DD5E8E80AQ69209091-0D5E9AC8-B8A9-464E-967D-B5172DD4C4E1
P921
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
description
chemická sloučenina
@cs
chemische verbinding
@nl
name
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
@en
type
label
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
@en
altLabel
alpha-D-galactosyl-(1→4)-beta-D-galactosyl-(1→4)-beta-D-glucosylceramide
@en
prefLabel
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
@en
P2153
P665
P683
P2017
[C@@H]1([C@@H]([C@H]([C@@H]([C ...... ](/C=C/CCCCCCCCCCCCC)O)NC(=O)*
P231
71965-57-6